title: A new era of drug therapy for idiopathic pulmonary fibrosis.
authors.affiliation: Hull York Medical School, Academic Respiratory Medicine, Centre for Cardiovascular and Metabolic Research, Castle Hill Hospital, Cottingham HU16 5JQ, UK.
authors.forename: Michael G
authors.initials: MG
authors.lastname: Crooks
authors.affiliation: Hull York Medical School, Academic Respiratory Medicine, Centre for Cardiovascular and Metabolic Research, Castle Hill Hospital, Cottingham HU16 5JQ, UK. Electronic address: s.hart@hull.ac.uk.
authors.forename: Simon P
authors.initials: SP
authors.lastname: Hart
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D007211:Indoles / Q000627:therapeutic use; D008875:Middle Aged; D011728:Pyridones / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007211:Indoles; D011728:Pyridones; C093844:pirfenidone; C530716:nintedanib